Jelli, B. et al. 2021. Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma. European Journal of Case Reports in Internal Medicine. 8, 8 (Aug. 2021). DOI:https://doi.org/10.12890/2021_002749.